The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
You gotta love blue gold.
Morning all, I check in most days but have nothing to offer comment wise. Thank you Ian for keeping on top of the guesses , can you put me down for 16p please.
I'm holding, waiting and seeing too.
Have a good and safe weekend all!
Agreed, that's a big investment over time as opposed to Yesod's p*ss taking offer.
I read it as "no offer".
But there are some wiser heads on here...
RNS Number : 5732E
Yesod Bio-Sciences Limited
28 February 2020
28 February 2020
Statement by Yesod Bio-Sciences Limited ("Yesod") regarding Redx Pharma Plc ("Redx")
Further to the announcement made by Redx on 14 February 2020 in which Redx announced that it was in discussions with a consortium of potential investors (the "Bidder") in relation to a possible cash offer to be made by the Bidder for the entire issued, and to be issued, share capital of Redx and that Redx had consented to an extension of the relevant deadline under Rule 2.6(a) of the UK City Code on Takeovers and Mergers (the "Code"), the Bidder, through its specially incorporated bid vehicle, Yesod, today confirms that it does not intend to make an offer for the entire issued and to be issued share capital of Redx pursuant to Rule 2.7 of the Code.
Under Note 2 on Rule 2.8 of the Code, the Bidder and/or Yesod and any person acting in concert with the Bidder and/or Yesod, reserves the right to set aside the restrictions in Rule 2.8 in the following circumstances: (i) with the agreement of the board of Redx; (ii) if a third party announces a firm intention to make an offer for Redx; (iii) if Redx announces a "whitewash" proposal (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); and (iv) if the Panel on Takeovers and Mergers determines there has been a material change of circumstances.